title: Successful clinical response to irinotecan in relapsed neuroblastoma.
authors.affiliation: Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan.
authors.forename: Toshiji
authors.initials: T
authors.lastname: Shitara
authors.forename: Akira
authors.initials: A
authors.lastname: Shimada
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Tsuchida
authors.forename: Norio
authors.initials: N
authors.lastname: Suzuki
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Toki
authors.forename: Minoru
authors.initials: M
authors.lastname: Kuroiwa
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009447:Neuroblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography; D016879:Salvage Therapy; D059004:Topoisomerase I Inhibitors; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002166:Camptothecin